Press Releases

Date Title  
Toggle Summary Allergen Research Corporation Announces $17 Million Series A Financing
Funds Will Support Phase 2b Clinical Trial for Peanut Allergy Oral Immunotherapy SAN MATEO, Calif., November 21, 2013— Allergen Research Corporation (ARC), a privately held company developing desensitization treatment protocols and products for food allergies, today announced the successful